Guiyang / Middlesex / Beverly / Ellisville / Mague / L. A. / Wilmington / San Diego / Lincoln / /
Company
Takemori A. E. / Chan A. S. / Li-Cor Biosciences / Ligand / Molecular Biology Inc. / Charles River Laboratories / Vinson N. A. / Stephens / Myers L. C. / AstraZeneca / /
Country
United States / United Kingdom / China / / /
Event
Product Recall / Product Issues / FDA Phase / /
Facility
Terminal Kinase Michael R. Bruchas / terminal Kinase* Received / National Institute / University of Washington / terminal Kinase / Traditional Chinese Medical University / Concord Pike / Research Triangle Institute / / /
IndustryTerm
above media / heterologous expression systems / therapeutic tools / cell systems / agonist binding site / cellular protein sorting machinery / /
National Institute of Health / National Institute on Drug Abuse / Department of Pharmacology / Institute on Drug Abuse Drug Program / Research Triangle Institute / Animal Care and Use Committee / University of Washington / Seattle / Traditional Chinese Medical University / American Society for Biochemistry / /
Person
Morgan / John Pintar / Selena Schreiber / Rothman / Nat / Atkinson / Ai / Tao Yang / Charles Chavkin / Ivy Carroll / Michael R. Bruchas / Mia DeFino / Steven C. Kwan / Dan Messenger / F. I. Carroll / Johnson / Chang / / /
Position
D. J. / R. N. / King / Messenger for assistance / representative / /